Does adding dextrose to intravenous fluids increase serum sodium concentration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Adding Dextrose to IV Fluids Increase Serum Sodium?

No, adding dextrose to intravenous fluids does NOT increase serum sodium concentration—in fact, dextrose is metabolically neutral and does not affect the tonicity of the solution, which is determined solely by the sodium content.

Understanding Dextrose and Tonicity

The confusion here stems from misunderstanding how dextrose affects fluid tonicity. Dextrose is rapidly metabolized upon infusion and therefore does not contribute to the effective osmolarity (tonicity) of IV solutions 1. The tonicity of IV fluids—and thus their effect on serum sodium—is determined primarily by the sodium and potassium concentration, not the dextrose content 1.

When calculating osmolarity for clinical purposes, dextrose is excluded from the calculation because it is metabolized so quickly 1. For example:

  • 0.9% NaCl has an osmolarity of 308 mOsm/L
  • D5 0.9% NaCl (with 5% dextrose added) still has an osmolarity of 308 mOsm/L for practical purposes

What Actually Happens with Dextrose

Research demonstrates that dextrose addition can actually be associated with DECREASED sodium levels, not increased 2. In a study of maternal IV loading, patients receiving 5% dextrose solution experienced:

  • A significant rise in glucose levels
  • A significant DECREASE in sodium levels in both mothers and newborns 2

This occurs because dextrose-containing hypotonic solutions provide free water (after dextrose metabolism) that can dilute serum sodium, particularly in patients with non-osmotic vasopressin release 1.

Clinical Evidence on Sodium Changes

Multiple high-quality studies confirm that the sodium concentration of the base solution—not dextrose content—determines serum sodium changes:

  • Isotonic fluids (0.9% saline) with dextrose added prevent hyponatremia with an odds ratio of 0.41 for developing hyponatremia compared to hypotonic fluids 3
  • Studies using isotonic solutions routinely added 2.5-5% dextrose without causing hypernatremia 1
  • In children receiving 0.9% saline in 5% dextrose, serum sodium remained stable or increased appropriately, while those receiving 0.45% saline in 5% dextrose experienced significant sodium drops 4, 5

Current Guideline Recommendations

The AAP strongly recommends isotonic solutions WITH dextrose (2.5-5%) for maintenance IV fluids in children 28 days to 18 years of age 1. This recommendation (Level A evidence, strong recommendation) is based on 17 randomized trials involving over 2,400 patients. The dextrose is added for metabolic support, not to affect sodium levels.

Key Clinical Pitfall to Avoid

The critical error is confusing osmolarity with tonicity. While dextrose increases the measured osmolarity of a solution, it does not increase tonicity because it's rapidly metabolized. Therefore:

  • Adding dextrose to hypotonic saline (0.45% NaCl) does NOT make it isotonic
  • The solution remains hypotonic and will still cause hyponatremia
  • Only the sodium content determines the effect on serum sodium levels

Bottom line: Dextrose serves as an energy source and prevents hypoglycemia during IV fluid therapy, but it does not shift or increase serum sodium concentration—the sodium content of the base solution is what matters.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.